Non-profit life sciences incubator Massachusetts Biomedical Initiatives (MBI) announced that three new companies joined its ...

We speak with a member of BioProcess International's editorial advisory board about the link between friendship and business.

But before we say goodbye to 2025, we leave you with five of our favorite features from this year, delving deeper into a few ...

BPI contributor Justin Byers is cofounder and chief executive officer of Axio BioPharma.

Authors explore complexities in scaling gene-therapy production with special attention is to monitoring and enhancing ...

Cell-line development enhances biopharmaceutical production capacity and quality, but complex biologics like bsAbs and ADCs present new challenges.

A new clinical trial has shown promising safety and efficacy results for liraglutide in the treatment of Alzheimer’s disease.

Biotechnology company Leucid Bio announced a strategic collaboration with Syenex, an open-source gene therapy platform firm.

The company is struggling to make ends meet as it loses a major undisclosed client.

Antimicrobial resistance (AMR) remains one of the most urgent public health threats of our time. By rendering existing antibiotics less effective or even useless, AMR threatens to roll back decades of ...

BioLife Solutions has announced the opening of its Aby J. Mathew Center for Biopreservation Excellence at its manufacturing campus in Bothell, Washington. The facility is designed to enable offering ...

Vaccine maker Moderna has announced a $140 million US manufacturing expansion at its existing Moderna Technology Center (MTC) in Norwood, Massachusetts. The project is envisioned to strengthen the ...